Dr. Robison is the Chief Medical Officer of Novamind Ventures. He is the co-founder of Cedar Psychiatry and a Coordinating investigator with MAPS the Multidisciplinary Association for Psychedelic Studies. Dr. Robison conducted his first research study involving psychedelics in 2011 so he’s been at this for quite some time.

I was honoured to have the opportunity to talk to Reid about the therapeutic uses of different psychedelics including psylicibin and ketamine.

Dr. Robison is at the forefront of a new revolution in the treatment of mental health and I had a great time picking his brain about this fascinating topic.

 

You will Learn:

-What are the long term effects of psychedelics in a therapeutic setting?

-When should psychedelics be used in a therapeutic setting?

-What are the uses of different psychedelics?

-Why would someone use Psylicibin vs Ketamine?

-How do you maintain the benefits of therapy?

-The many uses of Ketamine from extreme cases of depression to anorexia.